Re: Bacillus Calmette-Guerin versus epirubicin for primary, secondary or concurrent carcinoma in situ of the bladder: results of a European Organization for the Research and Treatment of Cancer-Genito-Urinary Group Phase III Trial (30906).
作者信息
Mehraban Darab, Esfahani Fatemeh
出版信息
J Urol. 2005 Sep;174(3):1151; author reply 1151. doi: 10.1097/01.ju.0000169425.93927.7a.
Abstract
摘要
Zotero 插件